https://www.barrons.com/articles/amgen-horizon-therapeutics-acquisition-stock-price-51670843416
0
0
12/12/22 at 1:11pm
Organization
Barron's
Author
Joe Woelfel
28 words
0
Comments
Amgen reaches a deal to buy drug company Horizon Therapeutics for $116.50 a share in cash.
You are the first to view
Create an account
or login to join the discussion